Literature DB >> 25820579

Public awareness of human papillomavirus as a causative factor for oropharyngeal cancer.

Michael U Williams1, Michele M Carr1, David Goldenberg2.   

Abstract

OBJECTIVE: To assess the public's awareness of human papillomavirus (HPV) as a causative factor for oropharyngeal cancer. STUDY
DESIGN: Twenty-three-item survey.
SETTING: Local shopping malls and Maxwell Air Force Base in 2012.
METHODS: Respondents were randomly chosen to participate in 23-item survey at various local shopping malls and at Maxwell Air Force Base in 2012. The χ(2) test was used in statistical analysis.
RESULTS: The majority of respondents (n = 319) were civilians; 158 were military officer trainees (MOTs). All MOTs had a bachelor's degree or higher, while 37% of civilian respondents had a bachelor's degree or higher. Most MOTs (82%) were aware of oropharyngeal cancer, and 53% of civilians had not heard of oropharyngeal cancer (P < .0001). Most respondents (73% civilian and 91% military) were aware of the association between HPV and cervical cancer. Conversely, 75% of civilian population and 49% of MOTs were not aware of the association between HPV and oropharyngeal cancer (P < .0001). The majority of respondents (61% military and 81% civilian) did not know that both sexes were eligible for HPV vaccine (P < .0001).
CONCLUSIONS: Most respondents were aware that HPV is a causative agent of cervical cancer. However, the majority were not aware of the association between oropharyngeal cancer and HPV. Furthermore, many respondents were not aware that HPV equally affects males and females and that the vaccine is available for both sexes. This underscores the need to educate the public on the availability of HPV vaccine and the association between HPV and oropharyngeal cancer. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  HPV; cancer; head and neck; military; oropharyngeal; oropharyngeal squamous cell cancer; otolaryngology; papilloma; public; vaccine

Mesh:

Substances:

Year:  2015        PMID: 25820579     DOI: 10.1177/0194599815577781

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.

Authors:  Eric Adjei Boakye; Daphne Lew; Meera Muthukrishnan; Betelihem B Tobo; Rebecca L Rohde; Mark A Varvares; Nosayaba Osazuwa-Peters
Journal:  Hum Vaccin Immunother       Date:  2018-06-01       Impact factor: 3.452

2.  Knowledge about human papillomavirus and prevention of cervical cancer among women of Arkhangelsk, Northwest Russia.

Authors:  Elena E Roik; Ekaterina E Sharashova; Evert Nieboer; Olga A Kharkova; Vitaly A Postoev; Jon Ø Odland
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

3.  Prevention of HPV-Related Oral Cancer by Dentists: Assessing the Opinion of Dutch Dental Students.

Authors:  Marcella R Poelman; Henk S Brand; Thymour Forouzanfar; Ellen M Daley; Derk H Jan Jager
Journal:  J Cancer Educ       Date:  2018-12       Impact factor: 2.037

4.  Awareness of HPV-associated oropharyngeal cancers among GPs in The Netherlands: a cross-sectional study.

Authors:  Imke Demers; Femke Verhees; Leo J Schouten; Jean Wm Muris; Bernd Kremer; Ernst Jan M Speel
Journal:  BJGP Open       Date:  2022-03-22

Review 5.  Head and neck cancer survivorship consensus statement from the American Head and Neck Society.

Authors:  Neerav Goyal; Andrew Day; Joel Epstein; Joseph Goodman; Evan Graboyes; Scharukh Jalisi; Ana P Kiess; Jamie A Ku; Matthew C Miller; Aru Panwar; Vijay A Patel; Assuntina Sacco; Vlad Sandulache; Amy M Williams; Daniel Deschler; D Gregory Farwell; Cherie-Ann Nathan; Carole Fakhry; Nishant Agrawal
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-30

6.  Public awareness of the association between human papillomavirus and oropharyngeal cancer.

Authors:  Femke Verhees; Imke Demers; Leo J Schouten; Matt Lechner; Ernst-Jan M Speel; Bernd Kremer
Journal:  Eur J Public Health       Date:  2021-10-26       Impact factor: 3.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.